{"id":48699,"date":"2012-06-30T06:22:28","date_gmt":"2012-06-30T06:22:28","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/nexdx-raises-2-6-million-in-series-b-financing-and-capital-term-loan.php"},"modified":"2012-06-30T06:22:28","modified_gmt":"2012-06-30T06:22:28","slug":"nexdx-raises-2-6-million-in-series-b-financing-and-capital-term-loan","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/molecular-medicine\/nexdx-raises-2-6-million-in-series-b-financing-and-capital-term-loan.php","title":{"rendered":"NexDx Raises $2.6 million in Series B Financing and Capital Term Loan"},"content":{"rendered":"<p>San Diego biotech NexDx, Inc., successfully closed a $2.1 million Series B financing led by founding investor, City Hill Ventures, LLC, and a $500,000 capital term loan from Silicon Valley Bank.San Diego, CA (PRWEB) June 29, 2012 NexDx, Inc., a science driven molecular diagnostics company providing next generation products and services for personalized medicine in rheumatoid arthritis and other ...<\/p>\n<p>Visit link:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/news.yahoo.com\/nexdx-raises-2-6-million-series-b-financing-073405787.html;_ylt=A2KJ3CQhm.5PsgEASbH_wgt.\" title=\"NexDx Raises $2.6 million in Series B Financing and Capital Term Loan\">NexDx Raises $2.6 million in Series B Financing and Capital Term Loan<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>San Diego biotech NexDx, Inc., successfully closed a $2.1 million Series B financing led by founding investor, City Hill Ventures, LLC, and a $500,000 capital term loan from Silicon Valley Bank.San Diego, CA (PRWEB) June 29, 2012 NexDx, Inc., a science driven molecular diagnostics company providing next generation products and services for personalized medicine in rheumatoid arthritis and other ... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/molecular-medicine\/nexdx-raises-2-6-million-in-series-b-financing-and-capital-term-loan.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[26],"tags":[],"class_list":["post-48699","post","type-post","status-publish","format-standard","hentry","category-molecular-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/48699"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=48699"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/48699\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=48699"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=48699"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=48699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}